Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands

Human Gene Therapy

Volumn 7, Issue 18, 1996, Pages 2255-2261

  O'Connell, Brian C ^a,e   Xu, Tao ^b   Walsh, Thomas J ^c   Sein, Tin ^c   Mastrangeli, Andrea ^d   Crystal, Ronald G ^d   Oppenheim, Frank G ^b   Baum, Bruce J ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b BOSTON UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FLUCONAZOLE; HISTATIN; PYRROLE; VIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MORBIDITY; MUCOSA; NONHUMAN; OPPORTUNISTIC INFECTION; RAT; SALIVARY GLAND; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; CANDIDA ALBICANS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030480194     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.18-2255     Document Type: Article

References (31)

1. ADESANYA, M.R., REDMAN, R.S., BAUM, B.J., and O'CONNELL, B.C. (1996). Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands. Hum. Gene Ther. 7, 1085-1093.
2. AZEN, E.A. (1973). Properties of salivary basic proteins showing polymorphism. Biochem. Genet. 9, 69-86.
3. AZEN, E.A., LEUTENEGGER, W., and PETERS, E.H. (1978). Evolutionary and dietary aspects of salivary basic (Pb) and post Pb (PPb) proteins in anthropod primates. Nature 273, 775-778.
4. BAUM, B.J., and O'CONNELL, B.C. (1995). The impact of gene therapy on dentistry. J. Am. Dent. Assoc. 126, 179-189.
5. BAUM, B.J., BIRD, J.L., MILLAR, D.B., and LONGTON, R.W. (1976). Studies on histidine-rich polypeptides from human parotid saliva. Arch. Biochem. Biophys. 177, 427-436.
6. BAUM, B.J., BIRD, J.L., and LONGTON, R.W. (1977a). Polyacrylamide gel electrophoresis of human salivary histidine-rich-polypeptides. J. Dent. Res. 56, 1115-1118.
7. BAUM, B.J., ELLISON, S.A., and LEVINE, M.J. (1977b). Differential antigenicity of human salivary histidine-rich polypeptides in goats and rabbits. Arch. Oral Biol. 22, 457-459.
8. COMO, J.A., and DISMUKES, W.E. (1994). Oral azole drugs as systemic antifungal therapy. N. Engl. J. Med. 330, 263-272.
9. EDGERTON, M., LO, T., and RAJ, P.A. (1996). Salivary histatin 3 and 5 exhibit specific binding to yeast cell membranes. J. Dent. Res. 75, 358.
10. GEORGOPAPADAKOU, N.H., and WALSH, T.J. (1994). Human mycoses: drugs and targets for emerging pathogens. Science 264, 371-373.
11. GRAHAM, F.L., and VAN DER EB, A.J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
12. GRAHAM, F.L., SMILEY, J., RUSSELL, W.C., and NAIRN, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-74.
13. HE, X.J., SHIP, J., WU, X.Z., BROWN, A.M., and WELLNER, R.B. (1989). Beta-adrenergic control of cell volume and chloride transport in an established rat submandibular cell line. J. Cell. Physiol. 138, 527-535.
14. KLEIN, R.S., HARRIS, C.A., SMALL, C.B., MOLL, B., LESSER, M., and FRIEDLAND, G.H. (1984). Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med. 311, 354-358.
15. LAL, K., POLLOCK, J.J., SANTARPIA, R.P.D., HELLER, H.M., KAUFMAN, H.W., FUHRER, J., and STEIGBIGEL, R.T. (1992). Pilot study comparing the salivary cationic protein concentrations in healthy adults and AIDS patients: correlation with antifungal activity. J. Acquir. Immune Defic. Syndr. 5, 904-914.
16. MASTRANGELI, A., O'CONNELL, B., ALADIB, W., FOX, P.C., BAUM, B.J., and CRYSTAL, R.G. (1994). Direct in vivo adenovirus-mediated gene transfer to salivary glands. Am. J. Physiol. 266, G1146-G1155.
17. McGRORY, W.J., BAUTISTA, D.S., and GRAHAM, F.L. (1988). A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163, 614-617.
18. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS. (1992). Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed Standard. NCCLS document M27-P. (NCCLS, Villanova, PA).
19. OPPENHEIM, F.G., XU, T., MCMILLIAN, F.M., LEVITZ, S.M., DIAMOND, R.D., OFFNER, G.D., and TROXLER, R.F. (1988). Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J. Biol. Chem. 263, 7472-7477.
20. POLLOCK, J.J., DENEPITIYA, L., MACKAY, B.J., and IACONO, V.J. (1984). Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans. Infect. Immun. 44, 702-707.
21. RAYHAN, R., XU, L., SANTARPIA, R.P.D., TYLENDA, C.A., and POLLOCK, J.J. (1992). Antifungal activities of salivary histidine-rich polypeptides against Candida albicans and other oral yeast isolates. Oral Microbiol. Immunol. 7, 51-52.
22. REX, J.H., RINALDI, M.G., and PFALLER, M.A. (1995). Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39, 1-8.
23. SHIRASUNA, K., SATO, M., and MIYAZAKI, T. (1981). A neoplastic epithelial duct cell line established from an irradiated human salivary gland. Cancer 48, 745-752.
24. VAN GINKEL, F.W., LIU, C., SIMECKA, J.W., DONG, J.Y., GREENWAY, T., FRIZZELL, R.A., KIYONO, H., MCGHEE, J.R., and PASCUAL, D.W. (1995). Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and beta-galactosidase. Hum. Gene Ther. 6, 895-903.
25. VAN DER SPEK, J.C., OFFNER, G.D., TROXLER, R.F., and OPPENHEIM, F.G. (1990). Molecular cloning of human submandibular histatins. Arch. Oral Biol. 35, 137-143.
26. WALSH, T.J. (1993). Fungal infections complicating pediatric AIDS. In Pediatric AIDS. P.A. Pizzo and C. Wilfert, eds. (Williams & Wilkins, Baltimore, MD) pp. 321-343.
27. XU, T., TELSER, E., TROXLER, R.F., and OPPENHEIM, F.G. (1990). Primary structure and anticandidal activity of the major histatin from parotid secretion of the subhuman primate, Macaca fascicularis. J. Dent. Res. 69, 1717-1723.
28. XU, T., LEVITZ, S.M., DIAMOND, R.D., and OPPENHEIM, F.G. (1991). Anticandidal activity of major human salivary histatins. Infect. Immun. 59, 2549-2554.
29. XU, L., LAI, K., SANTARPIA, R.P.D., and POLLOCK, J.J. (1993). Salivary proteolysis of histidine-rich polypeptides and the antifungal activity of peptide degradation products. Arch. Oral Biol. 38, 277-283.
30. YANG, Y., LI, Q., ERTL, H.C., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
31. ZSENGELLER, Z.K., WERT, S.E., HULL, W.M., HU, X., YEI, S., TRAPNELL, B.C., and WHITSETT, J.A. (1995). Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6, 457-467.